Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04146688
Other study ID # 2017_35
Secondary ID 2017-A03543-50
Status Recruiting
Phase N/A
First received
Last updated
Start date May 17, 2018
Est. completion date May 2021

Study information

Verified date November 2020
Source University Hospital, Lille
Contact François Puissieux, MD,PhD
Phone 3.20.44.46.02
Email francois.puisieux@chru-lille.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Musical interventions improve the emotional state of patients with Alzheimer's disease (AD) while having a positive impact on the caregiver's well-being. However, the factors that could be responsible for this positive effect remain unknown. Among these, the sensory-motor synchronization (SMS) of movements to the musical rhythm, frequently observed during musical activities and possible up to the advanced stages of AD, could modulate the emotional state. Several recent studies have shown that rhythmic training (or SMS) influences the organism at the motor, cognitive and social levels while activating the cerebral reward circuit. This action that generates pleasure also facilitates non-verbal emotional expression. However, the conditions that modulate SMS and their relationship to nonverbal communication, emotional, behavioral and cognitive state have not yet been studied in healthy or pathological elderly.


Recruitment information / eligibility

Status Recruiting
Enrollment 240
Est. completion date May 2021
Est. primary completion date May 2021
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: Cases : Patients with neurodegenerative disease (AD or related disease) - Native French Language - Corrected auditory and/or visual deficiency - Right-handed - Image rights consent signed by the patient Controls: People with no neuropathological disease - Native French Language - Corrected auditory and/or visual deficiency - Right-handed - Image rights consent signed by the control Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Music Balance Board
The SSM is measured with an innovative tool (Music Balance Board) developed at the University of Ghent (Belgium) and specially designed to record the movements of the elderly in a natural and comfortable position This chair is equipped with a tablet and sensors that record the movements of the hand and body during the SSM to a musical sequence. The analysis will focus on the difference between the participant's striking and the beat of the music measured using this chair.

Locations

Country Name City State
France Hôpital les Bateliers, CHU Lille

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Lille Fondation France Alzheimer

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary measure of consistency (oppositive of variability) measure of consistency (oppositive of variability) of the response corresponding to the length of a vector going from 0 (bad) to 1(very good response).
This measure is completed by another measure of asynchrony.
Baseline, before SMS task
Primary measure of asynchrony. The asynchrony assess the accuracy of the movements in ms. If the participant anticipated the tap relative to the musical beat, the value is negative, if the participant delayed the tap, the value is positive. A perfect tap is 0 in this case Baseline, before SMS task
Secondary Measurement of the Music Balance Board (cf. primary outcome) during music in the presence of a real experimenter measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV) Baseline, before SMS task
Secondary Measurement of the Music Balance Board (cf. primary outcome) during music in the presence of a virtual experimenter; measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV) after SMS task, an average after 45 min
Secondary Measurement of the Music Balance Board (cf. primary outcome) during metronome in the presence of a real experimenter measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV) after SMS task, an average after 45 min
Secondary Measurement of the Music Balance Board (cf. primary outcome) during metronome in the presence of a virtual experimenter. measure the quantity of movements derived from the variation of weight on the sensors below the platform in millivolts (mV) after SMS task, an average after 45 min
Secondary Decoding of non-verbal behaviors during the synchronization task Decoding of non-verbal behavior during the synchronization task (rhythmic movements of the head, lips and lower limbs, visual contact) in duration (duration of the behavior/duration of the Condition expressed in seconds) by blind evaluators in the membership group. after SMS task, an average after 45 min
Secondary Intensity of body movements (quantity of motion) Intensity of body movements (quantity of motion) recorded by the motion sensors connected to the chair on which the patient sits.
recorded during the SSM test and a filmed interview
after SMS task, an average after 45 min
Secondary STAI Anxiety Scale Score The State-Trait Anxiety Inventory (STAI) is a self-questionnaire, developed by Spielberger (7) and validated in French. It has 20 questions, assessing the subject's usual emotional state. A score is calculated, ranging from 20 to 80, a high score indicating the presence of anxiety. through study completion, an average of 2 hours
Secondary Decoding of the frequency (number of behaviors / duration of the condition) of the facial expressions the facial expressions based on videoscopic recordings of the synchronization task and a short interview (5min) by blind evaluators of the home group. through study completion, an average of 2 hours
Secondary Scale of Assessment of Daily Activities The ADLs used measure of functional ability is the Katz Activities of Daily Living Scale (Katz et al., 1963; Katx, 1983). In this scale, the set of tasks assessed are bathing, dressing, transferring, using the toilet, continence, and eating. through study completion, an average of 2 hours
Secondary Scale of Instrumental Activities of Daily Living The Lawton IADL Scale takes approximately 10 to 15 minutes to administer. It contains 8 items that are rated with a summary score from 0 (low functioning) to 8 (high functioning) through study completion, an average of 2 hours
Secondary Neuropsychiatric Inventory (NPI) subscales Impact on the workload of the caregiver. total NPI score is defined as the sum of the individual category scores. Higher scores on NPI indicate a more frequent and/or severe presence of neuropsychiatric behavioral changes. The following domains will be included in the subscore: Depression/Dysphoria, Anxiety, Apathy/Indifference, Irritability/Lability, Agitation/Aggression, and Disinhibition. through study completion, an average of 2 hours
Secondary mini-mental state examination (MMSE) score The Mini-Mental State Examination (MMSE) is a brief 30-point questionnaire test that is used to screen for cognitive impairment.
Scores on a scale range from 0 - 30. Scores 23 and below are indicative of problems.
through study completion, an average of 2 hours
Secondary Concentration of cortisol from saliva samples measure the saliva cortisol before and after the synchronization task Once, at Day 1, baseline
See also
  Status Clinical Trial Phase
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A